Global Retirement Partners LLC Has $73,000 Stake in Cardlytics, Inc. (NASDAQ:CDLX)

Global Retirement Partners LLC raised its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 54.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 19,800 shares of the company’s stock after purchasing an additional 7,000 shares during the period. Global Retirement Partners LLC’s holdings in Cardlytics were worth $73,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Tallon Kerry Patrick purchased a new position in shares of Cardlytics in the 4th quarter worth approximately $37,000. Atom Investors LP purchased a new position in shares of Cardlytics in the 3rd quarter worth approximately $33,000. Intech Investment Management LLC purchased a new position in shares of Cardlytics in the 3rd quarter worth approximately $47,000. SG Americas Securities LLC boosted its stake in shares of Cardlytics by 38.2% in the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after buying an additional 5,392 shares during the last quarter. Finally, Quadrature Capital Ltd purchased a new position in shares of Cardlytics in the 3rd quarter worth approximately $63,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Price Performance

Cardlytics stock opened at $2.63 on Friday. Cardlytics, Inc. has a 12 month low of $2.44 and a 12 month high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The business’s 50 day simple moving average is $3.34 and its 200 day simple moving average is $3.61. The company has a market cap of $133.66 million, a price-to-earnings ratio of -0.43 and a beta of 1.54.

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now owns 418,637 shares of the company’s stock, valued at $1,423,365.80. The trade was a 10.07 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Alexis Desieno sold 8,854 shares of the business’s stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the sale, the chief financial officer now directly owns 121,976 shares in the company, valued at $447,651.92. The trade was a 6.77 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 111,454 shares of company stock valued at $391,864 in the last 90 days. 4.40% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on CDLX shares. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.